DİŞ HEKİMLERİNİN DİŞ ÇIKARMA JELLERİ İLE İLGİLİ YAKLAŞIMLARI VE BİLGİ DÜZEYLERİ

Yıl 2023, Cilt: 24 Sayı: 3, 293 - 299, 13.07.2023

Burcu Güçyetmez Topal , Tuğba Tasa Yiğit , Sıdıka Beril Falay

https://doi.org/10.18229/kocatepetip.1166986

Cited By: 1

Öz

AMAÇ: Çalışmanın amacı, bir grup Türk diş hekiminin diş çıkarma jelleri konusundaki yaklaşımlarını ve bilgi düzeylerini değerlendirmektir.
GEREÇ VE YÖNTEM: Bu kesitsel çalışma için, iletişim bilgilerine ulaşılabilen diş hekimlerine (n=1829) üç bölüm ve yirmi sorudan oluşan bir anket gönderilmiştir. Reçete edilen her diş çıkarma jelinin içeriği, dozu ve yan etkileri için ayrı kategoriler oluşturulmuştur. Reçete edilen tüm jeller dikkate alınarak, diş hekimlerinin bilgi düzeyinin yüzdesi hesaplanmıştır.
BULGULAR: Çalışmaya toplam 484 diş hekimi dahil edildi. Araştırmaya katılan diş hekimlerinin yaklaşık yarısı (%51,2) ayda en az bir diş çıkarma jeli reçete ettiğini bildirdi. En çok reçete edilen diş çıkarma jelleri lidokain bazlı jeller (%70,9) olurken, bunu hyaluronik asit bazlı (%61,4) ve bitkisel bazlı jeller (%36) izledi. Diş hekimlerinin diş çıkarma jellerinin etken maddesi, dozu ve yan etkileri hakkındaki bilgi düzeyi medyanları sırasıyla %50, %25 ve %20 olduğu bulundu. Meslekteki yılı fazla olan dişhekimleri, jellerin etken maddesi ve yan etkileri hakkında mesleğe yeni başlayanlara göre daha fazla bilgiye sahipti (p<0.05). Yaşları 20-30 arasında olan diş hekimleri jel dozajı konusunda daha fazla bilgiye sahipti (p<0.05). Pedodontistler ve oral cerrahların jellerin yan etkileri konusundaki bilgi düzeylerinin diğer branşlara göre daha yüksek olduğu bulundu. (p<0.05). Uzman olmayan diş hekimlerinin diş çıkarma jelleri hakkındaki bilgi düzeyleri, uzman diş hekimlerine göre anlamlı düzeyde daha düşüktü (p<0.05).
SONUÇ: Sonuç olarak, diş hekimlerinin diş çıkarma jelleri hakkında yetersiz bilgiye sahip olduğu bulunmuştur. Diş hekimlerinin, bu jellerin yanlış ve kontrolsüz kullanımını önleyebilmek için daha fazla eğitime ihtiyacı bulunmaktadır.

Anahtar Kelimeler

Diş hekimleri, Lidokain, Diş çıkarma jelleri, Diş sürmesi

THE DENTISTS' ATTITUDES AND KNOWLEDGE LEVEL ABOUT TEETHING GELS

Öz

OBJECTIVE: The aim of the study was to evaluate a group of Turkish dentists' attitudes and level of knowledge about teething gels.
MATERIAL AND METHODS: For this cross-sectional study, a questionnaire consisting of three parts and twenty questions was sent to dentists (n=1829) whose contact information could be reached. Separate categories were created for ingredients, dosage, and side effects of each prescribed teething gel. The percentages of the knowledge level of the dentists were calculated considering all prescribed gels.
RESULTS: A total of 484 dentists were included in the study. Approximately half of the dentists (51.2%) participating in the study reported that they prescribed at least one teething gel per month. The most commonly prescribed teething gels were lidocaine-based gels (70.9%), followed by hyaluronic acid-based (61.4%) and herbal-based gels (36%). The medians of the knowledge level of dentists about active ingredients, dosage, and side effects of teething gels were 50%, 25%, and 20%, respectively. Dentists with more years in the profession have more knowledge about the active ingredient and side effects of gels than those who are newer in the profession (p<0.05). Dentists with the aged between 20-30 years had more knowledge about the dosage of gels (p<0.05). It was found that the knowledge level of pediatric dentists and oral surgeons about the side effects of gels was higher than other branches. (p<0.05). The knowledge level about teething gels of non-specialist dentists was significantly lower than specialists (p<0.05).
CONCLUSIONS: In conclusion, it was found that dentists had insufficient knowledge about teething gels. Dentists need more education to prevent misuse and uncontrolled use of these gels.

Anahtar Kelimeler

Dentists, Lidocaine, Teething gels, Tooth eruption

Kaynakça

• 1. Calcagno E, Barattini R. A therapeutic approach to paediatric oral disorders. Minerva Pediatr. 2018;70(2):175-81.
• 2. Alcântara C, Castro M, Noronha M, et al. Hyaluronic acid accelerates bone repair in human dental sockets: a randomized triple-blind clinical trial. Braz Oral Res. 2018;32(1):1–10.
• 3. Ni J, Shu R, Li C. Efficacy evaluation of hyaluronic acid gel for the restoration of gingival interdental papilla defects. J Oral Maxillofac Surg. 2019;77(12): 2467–74.
• 4. Wilson C. The trouble with teething misdiagnosis and misuse of topical medicament. J Paediatr Dent. 2002;12(3): 215–8.
• 5. Tsang A. Teething, teething pain and teething remedies. Int Dent SA. 2010;12(5):48–61.
• 6. Monaghan N. Teething products may be harmful to health. Br Dent J. 2019;227(6):485–7.
• 7. Rosu S, Montanaro F, Rosu A, Oancea R. Multicentre study on the efficacy and tolerability of a non-medicated patented gel for the relief of teething symptoms in infants. Ital J Dent Med. 2017;10(1):45–54.
• 8. Teoh L, Moses GM. Are teething gels safe or even necessary for our children? A review of the safety, efficacy and use of topical lidocaine teething gels. J Paediatr Child Health. 2020;56(4):502–5.
• 9. Balit CR, Lynch AM, Gilmore SP, Murray L, Isbister GK. Lidocaine and chlorhexidine toxicity in children resulting from mouth paint ingestion: A bottling problem. J Paediatr Child Health. 2006;42(6):350–3.
• 10. Wake M. Teething symptoms: cross sectional survey of five groups of child health professionals. BMJ. 2002;325(7368):814.
• 11. Honig PJ. Are today’s pediatricians using yesterday’s notions? J Pediatr. 1975;87(3):415–17.
• 12. Aliyu I, Peter I, Abubakar S, et al. Teething myths among health workers in a tertiary health facility. Med J Dr. 2018;11(4):291–5.
• 13. Eric J, Patel B, Chi J, et al. What are pharmacists recommending for infant teething treatment? J Am Pharm Assoc. 2018;58(1):79-83.
• 14. De Castro AM, De Oliveira FS, De Melo Abrão L, et al. Perception of parents of children with and without disabilities about teething disturbances and practices adopted. Brazilian J Oral Sci. 2013;12(6):76–9.
• 15. Owais AI, Zawaideh F, Bataineh O. Challenging parents’ myths regarding their children’s teething. Int J Dent Hyg. 2010;8(1):28–34.
• 16. Feldens A, Faraco M, Ottoni B, Feldens G. Teething symptoms in the first year of life and associated factors: a cohort study. J Clin Pediatr Dent. 2010;34(3):201–6.
• 17. Plutzer K, Spencer A. How first-time mothers perceive and deal with teething symptoms: a randomized controlled trial. Child Care Heal Dev. 2012;38(2):292–9.
• 18. Bolukbas N, Erbil N, Altunbas N. Traditional practices about child care of the mothers who owner 0-12 month baby. J Hum Sci. 2009;6(1):164-76.
• 19. Di Pierro F. Retrospective analysis of the effects of a gum gel intended to treat signs and symptoms of teething in infants. Int J Nutraceuticals, Functional Foods and Novel Foods. 2019;1(1):1-3.
• 20. D'Ercole S, Nanussi A, Tieri M, Barattini DF, Tripodi D. Hyaluronic acid-based medical device and oral disorders: can it be used in paediatric dentistry? J Biol regul homeost agents 2015;29(4):999–1005.
• 21. Hopper SM, McCarthy M, Tancharoen C, et al. Topical lidocaine to improve oral intake in children with painful infectious mouth ulcers: A blinded, randomized, placebo-controlled trial. Ann Emerg Med. 2014; 63(3):292–917.
• 22. Wolf D, Otto J. Efficacy and safety of a lidocaine gel in patients from 6 months up to 8 years with acute painful sites in the oral cavity: A randomized, placebo-controlled, double-blind, comparative study. Int. J Pediatr. 2015; 2015:1-6.
• 23. Casale M, Moffa A, Vella P, et al. Hyaluronic acid: perspectives in dentistry. A systematic review. Int J Immunopathol Pharmacol. 2016; 29(4):572-82.
• 24. FDA drug safety communications. FDA recommends not to use Lidocaine to treat teething pain and requires new boxed warning. Maryland, USA: US food and drug administration; 2014. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drugsafety-communication-fda-recommends-not-using-lidocaine-treatteething-pain-and-requires [accessed 12 August 2020].
• 25. American Academy of Pediatric Dentistry. Guideline on perinatal and infant oral health care. Pediat Dent Ref Man. 2016; 38:150–4.
• 26. Kilinc G, Edem P, Gunay T, et al. Complaints and approaches of mothers about growth of primary teeth of their children. Turkiye Klinikleri J Dental Sci. 2015;21(2):90.
• 27. Prado C, Oliveira D, Abrão M, et al. Perception of parents of children with and without disabilities about teething disturbances and practices adopted. Braz J Oral Sci. 2013;12(1):76-9.
• 28. Olczak-Kowalczyk D, Turska-Szybka A, Gozdowski D, et al. Longitudinal study of symptoms associated with teething: Prevalence and mothers’ practices. Pediatria Polska. 2016;91(6):533-40.
• 29. Wake M, Hesketh K, Allen MA. Parent beliefs about infant teething: A survey of Australian parents. J Paediatr Child Health. 1999;35(5):446–9.
• 30. American Academy of Pediatrics (AAP). Prevention of medication errors in the pediatric inpatient setting. Pediatrics. 2003;112:431-36.
• 31. Balicer RD, Kitai E. Methemoglobinemia caused by topical teething preparation: a case report. ScientificWorld Journal. 2004; 4(1):517–20.
• 32. Giard MJ, Uden DL, Whitlock DJ, Watson DM. Seizures induced by oral viscous lidocaine. Clin Pharm. 1983;2(2):110.
• 33. Curtis LA, Dolan TS, Seibert HE. Are one or two dangerous? Lidocaine and topical anesthetic exposures in children. J Emerg Med. 2009;37(1):32–9.
• 34. FDA Drug Safety Communication [04-07-2011]: Reports of a rare, but serious and potentially fatal adverse effect with the use of over-the-counter (OTC) benzocaine gels and liquids applied to the gums or mouth. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-reports-rare-serious-and-potentially-fatal-adverse-effect-use-over,Accessed on 18.01.2022.